New Key Statistics Module, Z-Score and F-Score
HKSE:08329 Key Ratios
| Market Cap HK$ M | 231.56 |
| Enterprise Value HK$ M | -86.12 |
| P/E(ttm) | 8.63 |
| PE Ratio without NRI | 13.80 |
| Forward PE Ratio | -- |
| Price/Book | 0.23 |
| Price/Sales | 0.20 |
| Price/Free Cash Flow | 5.52 |
| Price/Owner Earnings | 15.33 |
| Payout Ratio % | -- |
| Revenue (TTM) HK$ M | 1,172.00 |
| EPS (TTM) HK$ | 0.02 |
| Beneish M-Score | -2.6 |
| 10-y EBITDA Growth Rate % | -1.00 |
| 5-y EBITDA Growth Rate % | -2.20 |
| y-y EBITDA Growth Rate % | -44.60 |
| EV-to-EBIT | -2.13 |
| EV-to-EBITDA | -2.13 |
| PEG | -- |
| Shares Outstanding M | 1,678.00 |
| Net Margin (%) | 2.29 |
| Operating Margin % | 1.52 |
| Pre-tax Margin (%) | 2.92 |
| Quick Ratio | 1.95 |
| Current Ratio | 2.51 |
| ROA % (ttm) | 1.70 |
| ROE % (ttm) | 2.70 |
| ROIC % (ttm) | 0.96 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.95 |
HKSE:08329 Number of Guru Trades
HKSE:08329 Volume of Guru Trades
Gurus Latest Trades with HKSE:08329
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:08329 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shenzhen Neptunus Interlong Bio-Technique Co Ltd Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers